Lv2
170 积分 2022-02-17 加入
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial
10个月前
已完结
Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non–small cell lung cancer negative for EGFR mutation and ALK fusion
10个月前
已完结
[Expert consensus on PD-L1 expression testing in esophageal carcinoma in China]
11个月前
已完结
Immunohistochemical Analysis of HER2, EGFR, and Nectin-4 Expression in Upper Urinary Tract Urothelial Carcinoma
1年前
已完结
Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue
1年前
已完结
A comparative study of PD-L1 IHC assays using immune cell scoring and CPS in breast cancer
1年前
已关闭
The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer
1年前
已完结
Development and validation of a sensitive UHPLC–MS/MS method for quantitation of prucalopride in rat plasma and its application to pharmacokinetics study
1年前
已完结
A771726在大鼠体内肝肠循环的研究
2年前
已关闭
药物浓度-时间曲线双峰现象研究进展
2年前
已完结
皖公网安备34019202002308
